CoverageForm 410-K10-Q8-K13D13G13F

NSPR Inspiremd, Inc. - 8-K

Filed May 22, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001493152-26-025017
5.029.01

Item 5.02 - Departure/Election of Directors or Certain Officers

180 words

Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On
May 20, 2026, Mr. Paul Stuka notified InspireMD, Inc. (the “Company”) of his decision to not seek reelection as a Class I
director of the Board of Directors of the Company (the “Board”) at the Company’s 2027 Annual Meeting of Stockholders
(the “2027 Annual Meeting”) and to retire from the Board. Mr. Stuka’s decision did not result from any disagreement
with the Company on any matter relating to the Company’s operations, policies, practices or otherwise.

Mr.
Stuka is currently the Chair of the Board, the Chair of the Compensation Committee of the Board, and a member of the Audit Committee
and the Nominating and Corporate Governance Committee of the Board. Mr. Stuka currently expects to continue to serve in such capacities
until his term as a Class I director expires at the 2027 Annual Meeting. As part of succession planning, the Nominating and Corporate
Governance Committee of the Board plans to identify and evaluate suitable candidates for the Board.

Item 9.01 - Financial Statements and Exhibits

23 words

Item
9.01 Financial Statements and Exhibits.

(d)
Exhibits

Exhibit
Number

Description

104

Cover Page Interactive Data File (embedded within the
Inline XBRL document)